Scipher Medicine® and Ambry Genetics® Partner to Bring Precision Medicine Test for Rheumatoid Arthritis to Market
17. September 2020 08:00 ET | Scipher Medicine Corporation
PrismRA® first-of-its-kind molecular signature test validated in Ambry’s central laboratory.Partnership provides infrastructure for rapid scaling and patient accessibility. WALTHAM, Mass. and...